These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
249 related items for PubMed ID: 1549625
1. Suppression of murine hematopoiesis in vivo after chronic administration of zidovudine: evidence that zidovudine-induced anemia is the result of decreased bone marrow-derived, erythropoietin-responsive progenitor cells. Gallicchio VS, Hughes NK. Proc Soc Exp Biol Med; 1992 Apr; 199(4):459-65. PubMed ID: 1549625 [Abstract] [Full Text] [Related]
2. Prevention of hematopoietic myeloid and megakaryocyte toxicity associated with zidovudine in vivo in mice with recombinant GM-CSF. Gallicchio VS, Hughes NK, Tse KF. Growth Regul; 1994 Jun; 4(2):41-7. PubMed ID: 7950902 [Abstract] [Full Text] [Related]
3. Effect of interleukin-1, GM-CSF, erythropoietin, and lithium on the toxicity associated with 3'-azido-3'-deoxythymidine (AZT) in vitro on hematopoietic progenitors (CFU-GM, CFU-MEG, and BFU-E) using murine retrovirus-infected hematopoietic cells. Gallicchio VS, Hughes NK, Hulette BC, Noblitt L. J Leukoc Biol; 1991 Dec; 50(6):580-6. PubMed ID: 1940611 [Abstract] [Full Text] [Related]
4. Prevention of the hematopoietic toxicity associated with zidovudine in vivo with IL-1 alone or in combination with GM-CSF administered to normal mice. Gallicchio VS, Hughes NK, Tse KF, Gaines H. Growth Factors; 1993 Dec; 9(3):177-83. PubMed ID: 8274295 [Abstract] [Full Text] [Related]
8. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia. Wisniewski D, Strife A, Atzpodien J, Clarkson BD. Cancer Res; 1987 Sep 15; 47(18):4788-94. PubMed ID: 3040231 [Abstract] [Full Text] [Related]
10. Additive effect of erythropoietin and heme on murine hematopoietic recovery after azidothymidine treatment. Harrison J, Kappas A, Levere RD, Lutton JD, Chertkov JL, Jiang S, Abraham NG. Blood; 1993 Dec 15; 82(12):3574-9. PubMed ID: 8260696 [Abstract] [Full Text] [Related]
13. In situ radiation sensitivity of recombinant human granulocyte colony-stimulating factor-recruited murine circulating blood and bone marrow progenitors (colony-forming unit [CFU]-granulocyte-macrophage and CFU-megakaryocyte): evidence for possible biologic differences between mobilized blood and bone marrow. Scheding S, Media JE, KuKuruga MA, Nakeff A. Blood; 1996 Jul 15; 88(2):472-8. PubMed ID: 8695794 [Abstract] [Full Text] [Related]
14. Sustained zidovudine treatment on hematopoiesis in immunodeficient mice. Gallicchio VS, Hughes NK, Tse KF. Int J Immunopharmacol; 1993 Aug 15; 15(6):673-81. PubMed ID: 8407052 [Abstract] [Full Text] [Related]
15. Interaction of stem cell factor and its receptor c-kit mediates lodgment and acute expansion of hematopoietic cells in the murine spleen. Broudy VC, Lin NL, Priestley GV, Nocka K, Wolf NS. Blood; 1996 Jul 01; 88(1):75-81. PubMed ID: 8704204 [Abstract] [Full Text] [Related]
16. Expansion of granulocyte colony-stimulating factor/chemotherapy-mobilized CD34+ hematopoietic progenitors: role of granulocyte-macrophage colony-stimulating factor/erythropoietin hybrid protein (MEN11303) and interleukin-15. Pierelli L, Scambia G, Bonanno G, Coscarella A, De Santis R, Mele A, Battaglia A, Fattorossi A, Romeo V, Menichella G, Mancuso S, Leone G. Exp Hematol; 1999 Mar 01; 27(3):416-24. PubMed ID: 10089903 [Abstract] [Full Text] [Related]
17. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures. Lemoli RM, Gulati SC. Stem Cells; 1993 Sep 01; 11(5):435-44. PubMed ID: 7694721 [Abstract] [Full Text] [Related]
18. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment. Nijhof W, Goris H, Dontje B, Dresz J, Loeffler M. Exp Hematol; 1993 Apr 01; 21(4):496-501. PubMed ID: 8462658 [Abstract] [Full Text] [Related]
19. Acute toxic effects of 3'-azido-3'-deoxythymidine (AZT) on normal and regenerating murine hematopoiesis. Scheding S, Media JE, Nakeff A. Exp Hematol; 1994 Jan 01; 22(1):60-5. PubMed ID: 8282060 [Abstract] [Full Text] [Related]
20. Increased hematopoietic toxicity following administration of interferon-a with combination dideoxynucleoside therapy (zidovudine plus ddI) administered in normal mice. Gallicchio VS, Scott KW, Hughes NK, Tse KF, Gaines H, Kirk PR, Birch NJ. Life Sci; 1995 Jan 01; 56(3):PL71-81. PubMed ID: 7823768 [Abstract] [Full Text] [Related] Page: [Next] [New Search]